,,

Francine Z Marques1, Erin Nelson2, Po-Yin Chu2

  • 1From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.) and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne, Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences (F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T., S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash University, Melbourne, Australia; Department of Pathology, University of Melbourne, Australia (A.E.-O.); and Institute the Heart Centre, Alfred Hospital, Melbourne, Australia (D.M.K.). david.kaye@baker.edu.au francine.marques@baker.edu.au.

Circulation
|December 9, 2016
PubMed
まとめ

繊維が豊富な食事とアセテートサプリメントは 腸内微生物群を調節することで 心血管の健康を改善します これらの介入は血圧と心臓/腎臓繊維症を低下させ 心血管疾患の予防に有望な戦略を提供します